With Sudden Spotlight on Alvesco for COVID-19, Teijin Being Flooded with Inquiries

March 6, 2020
Teijin Pharma has been inundated with inquiries over its inhaled corticosteroid Alvesco (ciclesonide) since its use against the novel coronavirus disease COVID-19 in Japan was reported, while some people are fretting over stable supplies to patients with asthma, the drug’s...read more